Galapagos Stock (NASDAQ:GLPG)
Previous Close
$27.51
52W Range
$24.74 - $37.78
50D Avg
$30.32
200D Avg
$32.15
Market Cap
$1.84B
Avg Vol (3M)
$187.56K
Beta
0.30
Div Yield
-
GLPG Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.